[The value of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG PET) in diagnosis of neoplastic diseases].

@article{Hernndez2005TheVO,
  title={[The value of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG PET) in diagnosis of neoplastic diseases].},
  author={Gloria Ruiz Hern{\'a}ndez and Carmelo Romero de Avila Y Avalos and Jos{\'e} Luis Carreras Delgado},
  journal={Medicina clinica},
  year={2005},
  volume={124 6},
  pages={229-36}
}
Positron emission tomography (PET) has the ability to detect cancer based on molecular and biochemical processes within the tumor tissues. The most widely used radiotracer in oncology at this time is the glucose analogue 18F-fluoro-2-deoxy-D-glucose (18F-FDG). Like glucose, 18F-FDG is transported into cells by a glucose transporter protein and rapidly… CONTINUE READING